News

head uk2

Scientific news - Chitin and Chitosan

HMC 0309 185In this rubric we present you scientific news from the world of chitin and chitosan. Monthly you can find recent publications. We hope to arouse your interest in this biopolymer or to help you out. If you have any comments or if you do chitin or chitosan research and you want to publish your article on this page, This email address is being protected from spambots. You need JavaScript enabled to view it.

Have fun browsing on our pages!

rss

Extraction of chitin from insects

Published on

Tags: chitosan, chitin, insects, raw material source, deacetylation, production

Commercial extraction of chitin is mainly from the shells of crustaceans such as snow crabs. Fungi and insects are alternative sources of chitin, which are poorly usable so far. The expansion of insect farming for animal feed production in recent years has increased the availability of insect biomass. In the following, we present a review that provides an overview of recently published studies on the extraction of chitin from insects and its conversion to chitosan.

Biocompatibility assessment of medical devices in 4 steps - FDA recommendations

Published on

Tags: Biocompatibilty, FDA, medical device

Biological assessment or testing of the biocompatibility of medical devices is an essential part of conformity assessment. But how do I properly and efficiently assess the biocompatibility of my medical device? The FDA has published new recommendations for assessing the biocompatibility of medical devices.

SARS-CoV-2 research with chitosan - publications to date

Published on

Tags: chitosan, virus, Vaccines, vaccine production, SARS-CoV-2, Covid

The corona virus disease COVID-19 has changed the world. To combat the pandemic, researchers and companies around the world are working to develop vaccines and medicines. Chitosan also has potential in the area of vaccine development and functionalization of protective equipment such as respirators. We have prepared summaries of recent publications on chitosan as an aid in the fight against corona.

Carboxymethyl chitosan for treatment of liver carcinomas

Published on

Tags: cancer, carboxymethylchitosan, anticancer therapy

Hepatocellular carcinoma is a solid tumor that exhibits severe angiogenesis, cell cycle dysregulation, and evasion of apoptosis. Late diagnosis in a large proportion of patients is making the carcinomas inoperable, and various chemotherapeutic agents are used. Due to the numerous side effects of known chemotherapeutic agents, intensive research is performed on the use of natural products and their synthetic analogues. The authors of the presented study investigated the effect of carboxymethyl chitosan oligosaccharides on the growth of hepatocellular tumors in mice.

Congress and fairs

Meet us in person 2021:

  • EUCHIS, 2021
  • CPHI 2021
  • Medica 2021
  • Asia Pacific Chitin and Chitosan Symposium, 2021, South Korea

To arrange an appointment please contact Katja Richter via sales(at)medical-chitosan.com

Contact

  • Heppe Medical Chitosan GmbH
    Heinrich-Damerow-Strasse 1
    06120 Halle (Saale)
    Germany
  • Tel.: +49 (0) 345 27 996 300
    Fax: +49 (0) 345 27 996 378
  • sales@medical-chitosan.com

We use cookies on our website. Some of them are essential for the operation of the site, while others help us to improve this site and the user experience (tracking cookies). You can decide for yourself whether you want to allow cookies or not. Please note that if you reject them, you may not be able to use all the functionalities of the site.